Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
Saved in:
| Title: | Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia. |
|---|---|
| Authors: | Popovics P; Department of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.; Department of Urology, George M. O'Brien Center of Research Excellence, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.; Department of Urology, Case Western Reserve University, Cleveland, Ohio., Awadallah WN; Department of Urology, Case Western Reserve University, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Kohrt SE; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.; Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio., Case TC; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee., Miller NL; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee., Ricke EA; Department of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.; Department of Urology, George M. O'Brien Center of Research Excellence, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin., Huang W; Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin., Ramirez-Solano M; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Liu Q; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Vezina CM; Department of Urology, George M. O'Brien Center of Research Excellence, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.; Department of Comparative Biosciences, University of Wisconsin-Madison, Wisconsin.; Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, Wisconsin., Matusik RJ; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee., Ricke WA; Department of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.; Department of Urology, George M. O'Brien Center of Research Excellence, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin., Grabowska MM; Department of Urology, Case Western Reserve University, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.; Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio.; Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio. |
| Source: | The Prostate [Prostate] 2020 Jul; Vol. 80 (10), pp. 731-741. Date of Electronic Publication: 2020 May 01. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0045 |
|---|---|
| DOI: | 10.1002/pros.23986 |
